1. Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia. (23rd July 2020) Authors: Boccia, Ralph; Cooper, Nichola; Ghanima, Waleed; Boxer, Michael A; Hill, Quentin A.; Sholzberg, Michelle; Tarantino, Michael D.; Todd, Leslie K.; Tong, Sandra; Bussel, James B. Journal: British journal of haematology Issue: Volume 190:Number 6(2020) Page Start: 933 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗